Dai, J., Aoto, J., & Südhof, T. C. (2019). Alternative splicing of presynaptic neurexins differentially controls postsynaptic NMDA and AMPA receptor responses. Neuron, 102(5), 993-1008. https://doi.org/10.1016/j.neuron.2019.03.032

Fuccillo, M. V., & Pak, C. (2021). Copy number variants in neurexin genes: phenotypes and mechanisms. Current opinion in genetics & development, 68, 64-70. https://doi.org/10.1016/j.gde.2021.02.010

Pak, C., Danko, T., Zhang, Y., Aoto, J., Anderson, G., Maxeiner, S., ... & Südhof, T. C. (2015). Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1. Cell stem cell, 17(3), 316-328. https://doi.org/10.1016/j.stem.2015.07.017

Pak, C., Danko, T., Mirabella, V. R., Wang, J., Liu, Y., Vangipuram, M., ... & Südhof, T. C. (2021). Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived NRXN1-mutant neurons. Proceedings of the National Academy of Sciences, 118(22), e2025598118. https://doi.org/10.1073/pnas.2025598118

Sebastian, R., Jin, K., Pavon, N. et al. Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids. Nat Commun 14, 3770 (2023). https://doi.org/10.1038/s41467-023-39420-6

Wu, D., Zhu, J., You, L. et al. NRXN1 depletion in the medial prefrontal cortex induces anxiety-like behaviors and abnormal social phenotypes along with impaired neurite outgrowth in rat. J Neurodevelop Disord 15, 6 (2023). https://doi.org/10.1186/s11689-022-09471-9

Cameli, C., Viggiano, M., Rochat, M. J., Maresca, A., Caporali, L., Fiorini, C., ... & Maestrini, E. (2021). An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder. Journal of cellular and molecular medicine, 25(5), 2459-2470. https://doi.org/10.1111/jcmm.16161

Molloy, C. J., Cooke, J., Gatford, N. J., Rivera-Olvera, A., Avazzadeh, S., Homberg, J. R., ... & Gallagher, L. (2023). Bridging the translational gap: what can synaptopathies tell us about autism?. Frontiers in Molecular Neuroscience, 16. doi: 10.3389/fnmol.2023.1191323

Møller, R. S., Weber, Y. G., Klitten, L. L., Trucks, H., Muhle, H., Kunz, W. S., ... & EPICURE Consortium. (2013). Exon‐disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia, 54(2), 256-264. https://doi.org/10.1111/epi.12078

George Kirov, Dan Rujescu, Andres Ingason, David A. Collier, Michael C. O'Donovan, Michael J. Owen, Neurexin 1 (NRXN1) Deletions in Schizophrenia, Schizophrenia Bulletin, Volume 35, Issue 5, September 2009, Pages 851–854. https://doi.org/10.1093/schbul/sbp079

Todarello, G., Feng, N., Kolachana, B. S., Li, C., Vakkalanka, R., Bertolino, A., ... & Straub, R. E. (2014). Incomplete penetrance of NRXN1 deletions in families with schizophrenia. Schizophrenia research, 155(1-3), 1-7. https://doi.org/10.1016/j.schres.2014.02.023

Huang, A. Y., Yu, D., Davis, L. K., Sul, J. H., Tsetsos, F., Ramensky, V., ... & Smit, J. (2017). Rare copy number variants in NRXN1 and CNTN6 increase risk for Tourette syndrome. Neuron, 94(6), 1101-1111. https://www.cell.com/neuron/pdf/S0896-6273(17)30508-1.pdf

Nag, A., Bochukova, E. G., Kremeyer, B., Campbell, D. D., Muller, H., Valencia-Duarte, A. V., ... & Ruiz-Linares, A. (2013). CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. Plos one, 8(3), e59061. https://doi.org/10.1371/journal.pone.0059061

Brignell, A., St John, M., Boys, A., Bruce, A., Dinale, C., Pigdon, L., ... & Morgan, A. T. (2018). Characterization of speech and language phenotype in children with NRXN1 deletions. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(8), 700-708. https://doi.org/10.1002/ajmg.b.32664

Gudmundsson, O. O., Walters, G. B., Ingason, A., Johansson, S., Zayats, T., Athanasiu, L., ... & Stefansson, K. (2019). Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder. Translational psychiatry, 9(1), 258. https://doi.org/10.1038/s41398-019-0599-y

Lowther, C., Speevak, M., Armour, C. et al. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression. Genet Med 19, 53–61 (2017). https://doi.org/10.1038/gim.2016.54

Noh, H. J., Tang, R., Flannick, J., O’Dushlaine, C., Swofford, R., Howrigan, D., ... & Lindblad-Toh, K. (2017). Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder. Nature communications, 8(1), 774. https://doi.org/10.1038/s41467-017-00831-x

Viñas‐Jornet, M., Esteba‐Castillo, S., Gabau, E., Ribas‐Vidal, N., Baena, N., San, J., ... & Guitart, M. (2014). A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion. Molecular genetics & genomic medicine, 2(6), 512-521. https://doi.org/10.1002/mgg3.105

Ching, M. S., Shen, Y., Tan, W. H., Jeste, S. S., Morrow, E. M., Chen, X., ... & Children's Hospital Boston Genotype Phenotype Study Group. (2010). Deletions of NRXN1 (neurexin‐1) predispose to a wide spectrum of developmental disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153(4), 937-947. https://doi.org/10.1002/ajmg.b.31063

Dabell, M. P., Rosenfeld, J. A., Bader, P., Escobar, L. F., El‐Khechen, D., Vallee, S. E., ... & Shaffer, L. G. (2013). Investigation of NRXN1 deletions: clinical and molecular characterization. American Journal of Medical Genetics Part A, 161(4), 717-731. https://doi.org/10.1002/ajmg.a.35780

Hu, Z., Xiao, X., Zhang, Z., & Li, M. (2019). Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders. Molecular psychiatry, 24(10), 1400-1414. https://doi.org/10.1038/s41380-019-0438-9

Schaaf, C. P., Boone, P. M., Sampath, S., Williams, C., Bader, P. I., Mueller, J. M., ... & Cheung, S. W. (2012). Phenotypic spectrum and genotype–phenotype correlations of NRXN1 exon deletions. European Journal of Human Genetics, 20(12), 1240-1247. https://doi.org/10.1038/ejhg.2012.95

Montalbano, S., Krebs, M.D., Rosengren, A. et al. Analysis of exonic deletions in a large population study provides novel insights into NRXN1 pathology. npj Genom. Med. 9, 67 (2024). https://doi.org/10.1038/s41525-024-00450-8